Restricted accessResearch articleFirst published online 2000-05
Acute optic neuropathy and transverse myelopathy in patients with antiphospholipid antibody syndrome: Favorable outcome after treatment with anticoagulants and glucocorticoids
We describe two patients with established antiphospholipidsyndrome, who during periods of subtheraputic anticoagulation, developed acute optic neuropathy and transverse myelopathy. Treatment with optimal anticoagulation and high dose glucocorticoids was followed by resolution of the neurologic deficits.
Boumpas DT , Patronas NJ , Dalakas MC et al. Acute transverse myelitis in systemic lupus erythematosus:magnetic resonance imaging and review of the literature . J Rheumatol1990;17: 89–92 .
2.
Lavalle C , Pizarro S , Drenkard C et al. Transverse myelitis:a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies . J Rheumatol1990;17: 34–73 .
3.
Ijdo JW , Conti-Kelly AM , Greco P et al. Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses:MS or APS?Lupus1999;8: 109–115 .
4.
Bonnet F , Mercie P , Morlat P et al. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus . Lupus1999;8: 244–247 .
5.
Hughes GR . The antiphospholipid syndrome and `multiple sclerosis' .Lupus1999;8: 89-89 .
6.
Witkowsky AK . Generic warfarini:implications for patient care(Editorial) . Pharmacotherapy1997;17: 640–664 .
7.
Richton-Hewett S , Foster B , Apstein CS . Medical and economic consequences of a blinded oral anticoagulant brand change at a municipal hospital . Arch Int Med1988;148: 806–818 .
8.
Khamashta MA , Cuadrado MJ , Mujic F et al. The management of thrombosis in the antiphospholipid-antibody syndrome . N Engl J Med1995;332: 993–997 .
9.
Rosler DH , Conway MD , Anaya JM et al. Ischemic optic neuropathy and high-level anticardiolipin antibodies in primary Sjogren's syndrome . Lupus1995;4: 155–1554 .
10.
Wilson WA , Gharavi AB , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome:report of an international workshop . Arthritis Rheum1999;42: 1309–1310 .
11.
Harris EN , Gharavi AB , Mackworth-Young CG) et al. Lupoid sclerosis:a possible pathogenetic role for antiphospholipid antibodies . Ann Rheum Dis1985;44: 281–283
12.
Amigo MC , Garcia-Torres R , Robles M et al. Renal involevement in primary antiphospholipid syndrome . J Rheum1992;19: 1181–1185 .
13.
Andrianakos AA , Duffy J , Suzuki M , Sharp JT . Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature . Ann Int Med1975;83: 616–624 .
14.
Kenik JG , Krohn K , Kelly RB et al. Transverse myelitis and optic neuritis in systemic lupus erythematosus:a case report with magnetic resonance imaging findings . Arthritis Rheum1987;30: 947–950 .
15.
Sun KH , Liu WT , Tsai CY et al. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum . Ann Rheum Dis1992;51: 707–712 .
